Le Lézard
Classified in: Health, Science and technology
Subjects: NEW PRODUCTS/SERVICES, MISCELLANEOUS

Terranueva completes first harvest


L'ASSOMPTION, Quebec, July 17, 2019 (GLOBE NEWSWIRE) -- Corporation Terranueva (CSE: TEQ) ("Terranueva" or the "Company") is pleased to announce the completion of its first harvest in its certification, research and development unit ("CRDU").

"We are very pleased with the first results, the yield is higher than we expected, which allows us to confirm that our growing methodology is in line with the needs of the plant," said Pierre Ayotte, President and Chief Executive Officer of Terranueva.

"The quality of this first crop is the culmination of a lot of effort and attention and suggests that our strategy is the right one," added Chief Producer Manuel Moffatt.

This first crop will be tested in the laboratory in the coming days to validate its quality and confirm we are moving in the right direction. "On a qualitative basis, the product appears to us to be that of a high standard. The learning curve has not been easy, but everything suggests that we are on the right path," says Rafael Percopo, the company's Quality Director.

The second crop is progressing on schedule and should be harvested in early August.

About Terranueva:
Terranueva relies on research and development and operational efficiency to become a key player in the emerging cannabis industry. It aims to provide the Canadian and international markets with first-rate medicinal and recreational cannabis.

Terranueva Pharma Corporation, its wholly owned subsidiary, holds the necessary licenses from Health Canada to meet its mission. Operating in L'Assomption (Quebec), its mission is to produce cannabis with the highest standards in terms of efficiency, quality and stability. To achieve its goal, Terranueva Pharma is implementing a modular production approach, integrating the latest advances and innovations in process automation.
Learn more about Terranueva at www.terranueva.ca

CSE nor its services providers (as that terms defined in the policies) accept responsibility for the adequacy or accuracy of this press release.

For further information, please contact:

For Terranueva Corporation:

Pierre Monet, Chief Financial Officer
Téléphone : (514) 883-8733
[email protected] 


These press releases may also interest you

at 08:15
Blue Yonder, a leader in digital supply chain transformations, continues its forward momentum to revolutionize the supply chain and has today announced the signing of an agreement to acquire One Network Enterprises (One Network) for approximately...

at 08:13
In a significant move to address the heating and cooling needs of European families, Midea's Residential Air Conditioner Division (Midea RAC) unveiled its new CirQHP Family products at the Mostra Convegno Expocomfort (MCE) 2024. The CirQHP Family is...

at 08:00
Bidpath Inc., a leading provider of global online auction software, proudly announces the launch of AuctionPay, a cutting-edge payments platform designed to revolutionize auction payments. With a focus on efficiency, security, and user-centric...

at 08:00
Alebund Pharmaceuticals ("Alebund" or the "Company"), an integrated biopharmaceutical company focusing on developing innovative therapies for the treatment of renal diseases and related chronic conditions, announced today that the US Food and Drug...

at 08:00
SC Ventures, Standard Chartered's innovation, fintech investment and ventures arm, is leading a ?12 million (USD $13 million) Series A round for distributed cloud provider Hive, to increase access to sustainable, high-powered computing resources for...

at 08:00
Human Immunology Biosciences (HI-Biotm), a clinical-stage biotechnology company developing targeted therapies for patients with severe immune-mediated diseases (IMDs), today announced that two abstracts have been accepted for oral presentation at the...



News published on and distributed by: